-
IUPAC Name:2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid
Supplier Lead time Price, $ Pack Targetmol Chemicals IncShips from: United StatesTo:TBD POA1 mgDescription: 2-hydroxy-4-(2-hydroxy-6-pentadecyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)-6-methylbenzoic acid is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.For a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:10,12,24,26,38,40-hexahydroxy-4,16,20,30,34-pentamethyl-3,15,19,29,33-pentaoxatetracyclo[34.4.0.0⁸,¹³.0²²,²⁷]tetraconta-1(40),8,10,12,22,24,26,36,38-nonaene-2,6,14,18,28,32-hexone
Supplier Lead time Price, $ Pack Key Organics Limited (BIONET)Ships from: United KingdomTo:TBD POA1 gFor a custom pack size or bulk
please drop us a line:Enquire -
-
IUPAC Name:2-hydroxy-6-nonyl-4-(2-nonyl-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoyloxy)benzoic acid
Supplier Lead time Price, $ Pack MedChemExpressShips from: United StatesTo:TBD POA1 mgDescription: Names: PTP1B-IN-25; Product Description: PTP1B-IN-25 (Compound 19) is a PTP1B inhibitor with remarkable antiviral, antibacterial, and antidiabetic activities. PTP1B-IN-25 has IC50 values of 0.37 μM, 8.6 μM, 3.7 μM, and 29 μM against PTP1B, HIV, α-Glucosidase, and methicillin-resistant Staphylococcus aureus (MRSA) respectively; Target: Bacterial;Fungal;HIV;PhosphataseMedChemExpress EUShips from: SwedenTo:TBD POA1 mgDescription: Names: PTP1B-IN-25; Product Description: PTP1B-IN-25 (Compound 19) is a PTP1B inhibitor with remarkable antiviral, antibacterial, and antidiabetic activities. PTP1B-IN-25 has IC50 values of 0.37 μM, 8.6 μM, 3.7 μM, and 29 μM against PTP1B, HIV, α-Glucosidase, and methicillin-resistant Staphylococcus aureus (MRSA) respectively; Target: Bacterial;Fungal;HIV;PhosphataseFor a custom pack size or bulk
please drop us a line:Enquire -


